The role of molecular biology in personalized medicine – Pr Hélène Blons

How do we identify the genetic alterations that make it possible to consider a targeted therapy, if it exists? Pr Hélène Blons, Molecular Biologist at the Georges-Pompidou European Hospital in Paris (AP-HP), explains the role of molecular typing of tumors in personalized medicine. This typing makes it possible to make a therapeutic choice based on the identification of genetic alterations in the tumors and thus to determine the best possible care for each patient.

RELEASES

INFORMATION

Calls for projects

2018 calls for projects are open !

Trainings

2018 trainings

Job offers

Check our job offers

Contacts

For more information, please contact